KELLY MINUS: Open Payments
NPI 1083922637 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,825 in 31 payments from 6 companies in 2025. Trend: 2023 $825 · 2024 $3,502 · 2025 $1,825
Consulting: $928Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $1,419 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $177 |
| Intra-Sana Laboratories | 2 | $143 |
| Corcept Therapeutics | 2 | $44 |
| Lilly USA, LLC | 1 | $24 |
| Currax Pharmaceuticals LLC | 1 | $17 |
Products named: Wegovy, JARDIANCE, RELTONE 200 MG, Korlym, Rybelsus, MOUNJARO, CONTRAVE.
Industry payments across NY — which companies pay providers there.
